Edouard-Jules Laforgue (Edouard Laforgue)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Health Insurance

Tyrosine Kinase

Respiratory Syndrome Coronavirus

Clinical Practice

Top Venues

International journal of environmental research and public health

British journal of clinical pharmacology

Expert opinion on drug safety

International journal of geriatric psychiatry

This page only lists publications with an associated author ORCID identifier.

Publications

Marion Istvan, Mélanie Duval, Karl Hodel, Aurélie Aquizerate, Anicet Chaslerie, Pascal Artarit, Edouard-Jules Laforgue, Caroline Victorri-Vigneau
Evolution of the profiles of new psychotropic drug users before and during the COVID-19 crisis: an original longitudinal approach through multichannel sequence analysis using the French health-care database. European archives of psychiatry and clinical neuroscience (2024)
Aurélie Aquizerate, Edouard-Jules Laforgue, Marion Istvan, Morgane Rousselet, Marie Gerardin, Emilie Jouanjus, Frédéric Libert, null null, Marylène Guerlais, Caroline Victorri-Vigneau
French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change. European journal of public health (2023)
Edouard-Jules Laforgue, Marion Istvan, Anicet Chaslerie, Pascal Artarit, Geneviève Vallot, Pascale Jolliet, Marie Grall-Bronnec, Caroline Victorri-Vigneau
Characterization of antipsychotic utilization before clozapine initiation for individuals with schizophrenia: an innovative visualization of trajectories using French National Health Insurance data. Epidemiology and psychiatric sciences 32 (2023)
Marion Istvan, Morgane Rousselet, Edouard-Jules Laforgue, Marylène Guerlais, Marie Gérardin, Pascale Jolliet, Fanny Feuillet, Caroline Victorri-Vigneau
Did the pattern of use of zolpidem change since the enforcement of a new prescription rule? A latent class analysis using the French health insurance database. Expert opinion on drug safety 21 (9) (2022)
Edouard-Jules Laforgue, Morgane Rousselet, Antoine Claudon, Aurélie Aquizerate, Pascale Jolliet, Marion Istvan, Caroline Victorri-Vigneau
Did the New French Regulation of Zolpidem Decrease the Problematic Consumption of Zolpidem? A Field Study among Users. International journal of environmental research and public health 19 (15) (2022)
Edouard-Jules Laforgue, Marion Istvan, Benoît Schreck, Marie Mainguy, Pascale Jolliet, Marie Grall-Bronnec, Caroline Victorri-Vigneau
Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior. Journal of clinical medicine 11 (8) (2022)
Morgane Guillou-Landreat, Antoine Dany, Gaëlle Challet-Bouju, Edouard-Jules Laforgue, Juliette Leboucher, Jean-Benoit Hardouin, Caroline Victorri-Vigneau, Marie Grall-Bronnec
What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report. International journal of environmental research and public health 18 (4) (2021)
Marion Istvan, Pascal Caillet, Morgane Rousselet, Marylène Guerlais, Edouard-Jules Laforgue, Marie Gérardin, Pascale Jolliet, Fanny Feuillet, Caroline Victorri-Vigneau
Change in the regulatory framework for zolpidem: What is the impact on the landscape of the prescription of sedative medications? The French national ZORRO study. British journal of clinical pharmacology 87 (8) (2021)
Edouard-Jules Laforgue, Marion Istvan, Marylène Guerlais, Anicet Chaslerie, Pascal Artarit, Genevieve Vallot, Pascale Jolliet, Marie Grall-Bronnec, Caroline Victorri-Vigneau
What about regular hematological monitoring during clozapine treatment? A compliance analysis using the French health insurance database. Expert opinion on drug safety 20 (10) (2021)
Alexandra Jobert, Marion Istvan, Edouard-Jules Laforgue, Benoît Schreck, Caroline Victorri-Vigneau
Regulatory Framework Implementation for the Prescription of Zolpidem in France, What Impact in the Older People? International journal of environmental research and public health 18 (22) (2021)
Marion Istvan, Edouard-Jules Laforgue, Marylène Guerlais, Pascale Jolliet, Caroline Victorri-Vigneau
ZORRO: When the mask falls off-Comment. British journal of clinical pharmacology (2021)
Caroline Victorri-Vigneau, Edouard-Jules Laforgue, Marie Grall-Bronnec, Morgane Guillou-Landreat, Morgane Rousselet, Marylène Guerlais, null null, Fanny Feuillet, Pascale Jolliet
Are Seniors Dependent on Benzodiazepines? A National Clinical Survey of Substance Use Disorder. Clinical pharmacology and therapeutics 109 (2) (2020)
Edouard-Jules Laforgue, Alexandra Jobert, Morgane Rousselet, Marie Grall-Bronnec, null null, Pascale Jolliet, Fanny Feuillet, Caroline Victorri-Vigneau
Do older people know why they take benzodiazepines? A national French cross-sectional survey of long-term consumers. International journal of geriatric psychiatry 35 (8) (2020)
Caroline Victorri-Vigneau, Céline Verstuyft, Régis Bouquié, Edouard-Jules Laforgue, Jean-Benoit Hardouin, Juliette Leboucher, Bertrand Le Geay, Corine Dano, Gaëlle Challet-Bouju, Marie Grall-Bronnec
Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study. British journal of clinical pharmacology 85 (7) (2019)